Targeted Strategies for Today's Evolving Markets

MissionIR Blog

TapImmune (TPIV) Presents at Rodman & Renshaw Conference

TapImmune Inc. (OTCQB: TPIV) is an immunotherapy company specializing in the development of innovative technologies for the treatment of cancer and infectious diseases. The company’s peptide or nucleic acid-based immunotherapeutics comprise one or more naturally processed epitopes designed to comprehensively stimulate patients’ T-cells while restoring or further augmenting antigen presentation. TapImmune’s technologies are suitable for use as stand-alone medications, as well as in combination with current treatment modalities. For more information, visit the company’s website at www.tapimmune.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research and sales and trading services to institutional investors. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.
This entry was posted in Rodman and Renshaw Conference. Bookmark the permalink.

Comments are closed.